205 related articles for article (PubMed ID: 36875134)
1. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
Front Immunol; 2023; 14():980711. PubMed ID: 36875134
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic.
Moorlag SJCFM; Taks E; Ten Doesschate T; van der Vaart TW; Janssen AB; Müller L; Ostermann P; Dijkstra H; Lemmers H; Simonetti E; Mazur M; Schaal H; Ter Heine R; van de Veerdonk FL; Bleeker-Rovers CP; van Crevel R; Ten Oever J; de Jonge MI; Bonten MJ; van Werkhoven CH; Netea MG
Clin Infect Dis; 2022 Aug; 75(1):e938-e946. PubMed ID: 35247264
[TBL] [Abstract][Full Text] [Related]
3. BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial.
Claus J; Ten Doesschate T; Gumbs C; van Werkhoven CH; van der Vaart TW; Janssen AB; Smits G; van Binnendijk R; van der Klis F; van Baarle D; Paganelli FL; Leavis H; Verhagen LM; Joosten SA; Bonten MJM; Netea MG; van de Wijgert JHHM;
mBio; 2023 Apr; 14(2):e0035623. PubMed ID: 36976004
[TBL] [Abstract][Full Text] [Related]
4. Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial.
Koekenbier EL; Fohse K; van de Maat JS; Oosterheert JJ; van Nieuwkoop C; Hoogerwerf JJ; Grobusch MP; van den Bosch MAAJ; van de Wijgert JHH; Netea MG; Rosendaal FR; Bonten MJM; Werkhoven CHHV;
Clin Microbiol Infect; 2023 Jun; 29(6):781-788. PubMed ID: 36736662
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses.
DiNardo AR; Arditi M; Kamat AM; Koster KJ; Carrero S; Nishiguchi T; Lebedev M; Benjamin AB; Avalos P; Lozano M; Moule MG; McCune B; Herron B; Ladki M; Sheikh D; Spears M; Herrejon IA; Dodge C; Kumar S; Hutchison RW; Ofili TU; Opperman LA; Bernard JA; Lerner SP; Udeani G; Neal G; Netea MG; Cirillo JD
Trials; 2023 Oct; 24(1):636. PubMed ID: 37794431
[TBL] [Abstract][Full Text] [Related]
6. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.
Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH
Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606
[TBL] [Abstract][Full Text] [Related]
7. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
[TBL] [Abstract][Full Text] [Related]
8. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.
Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC
Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502
[TBL] [Abstract][Full Text] [Related]
9. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
10. ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.
Tsilika M; Taks E; Dolianitis K; Kotsaki A; Leventogiannis K; Damoulari C; Kostoula M; Paneta M; Adamis G; Papanikolaou I; Stamatelopoulos K; Bolanou A; Katsaros K; Delavinia C; Perdios I; Pandi A; Tsiakos K; Proios N; Kalogianni E; Delis I; Skliros E; Akinosoglou K; Perdikouli A; Poulakou G; Milionis H; Athanassopoulou E; Kalpaki E; Efstratiou L; Perraki V; Papadopoulos A; Netea MG; Giamarellos-Bourboulis EJ
Front Immunol; 2022; 13():873067. PubMed ID: 35865520
[TBL] [Abstract][Full Text] [Related]
11. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
12. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19.
Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M
Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
Front Immunol; 2023; 14():1208659. PubMed ID: 37292214
[TBL] [Abstract][Full Text] [Related]
15. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
16. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
[TBL] [Abstract][Full Text] [Related]
18. BCG vaccination provides protection against IAV but not SARS-CoV-2.
Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
[TBL] [Abstract][Full Text] [Related]
20. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
